Evidence map›Paper›PMID 36306061›Full record

ArticleInternational journal of clinical pharmacy2023

Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national.

E Mantzourani, O Brooks, D James, A Richards, K Hodson, H Akhtar, M Wakelyn, L White, R Williams, G O'Gorman and 3 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Thank you from the Editor-in-Chief.International journal of clinical pharmacy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

E MantzouraniCardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK. Mantzouranie1@cardiff.ac.uk.ORCID https://orcid.org/0000-0002-6313-1409
O BrooksCardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK.
D JamesRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
A RichardsRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
K HodsonCardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK.
H AkhtarCardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK.
M WakelynRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
L WhiteRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
R WilliamsRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
G O'GormanRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
A KervinRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
J ChessRenal Pharmacy, Swansea Bay University Health Board, Swansea, Wales, UK.
C BrownCardiff School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, Wales, UK.
Swansea Bay University Health Board · GBCardiff University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment for people with kidney disease is often associated with complicated combinations of medicines. Logistical challenges with traditiona paper-based prescribing means that these patients are particularly susceptible to medication-relation errors and harm.

aimTo improve the quality of care that people with kidney disease receive across Wales through a Value-Based digital transformation programme.

settingRenal units within the National Welsh Renal Clinical Network (WRCN). DEVELOPMENT: A novel Electronic Prescribing & Medicines Administration (EPMA) system, integrated into a patient care record and linked to a patient portal was developed in South West Wales (SWW) region of the WRCN, enabled by the Welsh Government (WG) Efficiency Through Technology Fund. National upscale was enabled through the WG Transformation Fund. IMPLEMENTATION: EPMA was designed and rolled out initially in SWW region of the WRCN (2018). A dedicated delivery team used the blueprint to finalise and implement a strategy for successful national roll-out eventually across all Wales (completed 2021). EVALUATION: A multi-factorial approach was employed, as both the technology itself and the healthcare system within which it would be introduced, were complex. Continuous cycles of action research involving informal and formal qualitative interviews with service-users ensured that EPMA was accessible and optimally engaging to all target stakeholders (patients and staff). Results confirmed that EPMA was successful in improving the quality of care that people with kidney disease receive across Wales, contributed to Value-Based outcomes, and put people who deliver and access care at the heart of transformation.

conclusionKey findings of this study align directly with the national design principles to drive change and transformation, put forward by the WG in their plan for Health and Social Care: prevention and early intervention; safety; independence; voice; seamless care.

Indexed as

Delivery of Health CareHumansWalesElectronic prescribing patient careKidney diseasePatient portalQuality of care

Identifiers

PMID36306061
PMCPMC9614750
OpenAlexW4307776790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.